Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

Thymosin β4 promotes hair growth by activating stem cells in hair follicles.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

The research showed how melanocytes develop, move, and respond to UV light, and their stem cells' role in hair color and skin cancer risk.

Thymosin β4 helps improve skin healing and reduce scarring.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Innovative methods are reducing animal testing and improving biomedical research.

Gray hair can potentially be reversed, leading to new treatments.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Hibiscus plant extracts may have health benefits like lowering blood pressure and protecting the heart.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

PRP helps skin heal, possibly through special cells called telocytes.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document lists various dermatology topics, treatments, and diagnostic methods.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.